| __timestamp | AstraZeneca PLC | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5842000000 | 94103000 |
| Thursday, January 1, 2015 | 4646000000 | 146194000 |
| Friday, January 1, 2016 | 4126000000 | 130000 |
| Sunday, January 1, 2017 | 4318000000 | 7353000 |
| Monday, January 1, 2018 | 4936000000 | 34193000 |
| Tuesday, January 1, 2019 | 4921000000 | 56586000 |
| Wednesday, January 1, 2020 | 5299000000 | 63382000 |
| Friday, January 1, 2021 | 12437000000 | 97049000 |
| Saturday, January 1, 2022 | 12391000000 | 139989000 |
| Sunday, January 1, 2023 | 8040000000 | 150343000 |
| Monday, January 1, 2024 | 10207000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, cost efficiency is a critical metric for success. Over the past decade, AstraZeneca PLC and Sarepta Therapeutics, Inc. have showcased contrasting approaches to managing their cost of revenue. AstraZeneca, a global leader, has consistently maintained a high cost of revenue, peaking in 2021 with a staggering 85% increase from 2016. In contrast, Sarepta, a niche player, has demonstrated a more volatile yet controlled cost structure, with its highest cost of revenue in 2023, marking a 15-fold increase from 2016. This divergence highlights AstraZeneca's expansive operations and Sarepta's focused innovation strategy. As the industry faces new challenges, understanding these dynamics offers valuable insights into the strategic priorities of these pharmaceutical giants.
Cost Insights: Breaking Down AstraZeneca PLC and Novartis AG's Expenses
Cost Insights: Breaking Down AstraZeneca PLC and Sanofi's Expenses
Cost of Revenue Comparison: AstraZeneca PLC vs Pfizer Inc.
AstraZeneca PLC vs Sarepta Therapeutics, Inc.: Examining Key Revenue Metrics
Analyzing Cost of Revenue: AstraZeneca PLC and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: AstraZeneca PLC vs Amphastar Pharmaceuticals, Inc.
AstraZeneca PLC vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Viatris Inc. vs Sarepta Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Sarepta Therapeutics, Inc. vs Exelixis, Inc.
Cost of Revenue Trends: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and ADMA Biologics, Inc.'s Expenses
Cost of Revenue Comparison: Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.